カテゴリ： 世界, 医療/バイオ, QYResearch

好酸球性喘息治療薬の世界市場2023年：静脈内注射、皮下注射

■ 英語タイトル：Global Eosinophilic Asthma Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8751）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8751
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：89
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[好酸球性喘息治療薬の世界市場2023年：静脈内注射、皮下注射]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は好酸球性喘息治療薬のグローバル市場について調査・分析し、世界の好酸球性喘息治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（静脈内注射、皮下注射）、用途別セグメント分析（子供、大人、青少年）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、AstraZeneca、GSK、Genentech (Roche Group) & Novartis、Regeneron Pharmaceuticals & Sanofi、Teva Pharmaceuticalsなどが含まれています。好酸球性喘息治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、好酸球性喘息治療薬市場規模を算出する際に考慮しました。

・好酸球性喘息治療薬市場の概要
- 好酸球性喘息治療薬の種類別セグメント
- 世界の好酸球性喘息治療薬市場規模：タイプ別分析（静脈内注射、皮下注射）
- 好酸球性喘息治療薬の用途別セグメント
- 世界の好酸球性喘息治療薬市場規模：用途別分析（子供、大人、青少年）
- 世界の好酸球性喘息治療薬市場規模予測（2018年-2029年）

・好酸球性喘息治療薬市場の成長トレンド
- 好酸球性喘息治療薬の地域別市場規模（2018年-2029年）
- 好酸球性喘息治療薬市場ダイナミクス
- 好酸球性喘息治療薬の業界動向
- 好酸球性喘息治療薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：静脈内注射、皮下注射
- 世界の好酸球性喘息治療薬のタイプ別市場規模（2018年-2023年）
- 世界の好酸球性喘息治療薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：子供、大人、青少年
- 世界の好酸球性喘息治療薬の用途別市場規模（2018年-2023年）
- 世界の好酸球性喘息治療薬の用途別市場規模（2024年-2029年）

・好酸球性喘息治療薬の地域別市場規模
- 北米の好酸球性喘息治療薬市場規模（2018年-2029年）
- 米国の好酸球性喘息治療薬市場規模（2018年-2029年）
- ヨーロッパの好酸球性喘息治療薬市場規模（2018年-2029年）
- アジア太平洋の好酸球性喘息治療薬市場規模（2018年-2029年）
- 中国の好酸球性喘息治療薬市場規模（2018年-2029年）
- 日本の好酸球性喘息治療薬市場規模（2018年-2029年）
- 韓国の好酸球性喘息治療薬市場規模（2018年-2029年）
- インドの好酸球性喘息治療薬市場規模（2018年-2029年）
- オーストラリアの好酸球性喘息治療薬市場規模（2018年-2029年）
- 中南米の好酸球性喘息治療薬市場規模（2018年-2029年）
- 中東・アフリカの好酸球性喘息治療薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
AstraZeneca、GSK、Genentech (Roche Group) & Novartis、Regeneron Pharmaceuticals & Sanofi、Teva Pharmaceuticals

・アナリストの観点/結論

・調査手法と情報源

Eosinophilic asthma (EA) is a type of severe asthma. It’s marked by high levels of white blood cells. This report mianly studies Eosinophilic Asthma Treatment market.
Highlights
The global Eosinophilic Asthma Treatment market was valued at US$ 19100 million in 2022 and is anticipated to reach US$ 136480 million by 2029, witnessing a CAGR of 38.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key Eosinophilic Asthma treatment brands include Regeneron Pharmaceuticals & Sanofi, Genentech (Roche Group) & Novartis and GSK etc. The top 3 companies hold a share about 88%. North America is the largset market with a share about 40%, followed by Europe and Asia-Pacific.
In terms of treatment, subcutaneous injection is the largest segment with a share of 95%. And in terms of end users, adult is the largest end user with a share about 55%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Eosinophilic Asthma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eosinophilic Asthma Treatment.
The Eosinophilic Asthma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Eosinophilic Asthma Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eosinophilic Asthma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AstraZeneca
GSK
Genentech (Roche Group) & Novartis
Regeneron Pharmaceuticals & Sanofi
Teva Pharmaceuticals
Segment by Type
Intravenous Infusion
Subcutaneous Injection
Segment by Application
Children
Adults
Teenagers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eosinophilic Asthma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eosinophilic Asthma Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Intravenous Infusion
1.2.3 Subcutaneous Injection
1.3 Market by Application
1.3.1 Global Eosinophilic Asthma Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Children
1.3.3 Adults
1.3.4 Teenagers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Eosinophilic Asthma Treatment Market Perspective (2018-2029)
2.2 Eosinophilic Asthma Treatment Growth Trends by Region
2.2.1 Global Eosinophilic Asthma Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Eosinophilic Asthma Treatment Historic Market Size by Region (2018-2023)
2.2.3 Eosinophilic Asthma Treatment Forecasted Market Size by Region (2024-2029)
2.3 Eosinophilic Asthma Treatment Market Dynamics
2.3.1 Eosinophilic Asthma Treatment Industry Trends
2.3.2 Eosinophilic Asthma Treatment Market Drivers
2.3.3 Eosinophilic Asthma Treatment Market Challenges
2.3.4 Eosinophilic Asthma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Eosinophilic Asthma Treatment Players by Revenue
3.1.1 Global Top Eosinophilic Asthma Treatment Players by Revenue (2018-2023)
3.1.2 Global Eosinophilic Asthma Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Eosinophilic Asthma Treatment Revenue
3.4 Global Eosinophilic Asthma Treatment Market Concentration Ratio
3.4.1 Global Eosinophilic Asthma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eosinophilic Asthma Treatment Revenue in 2022
3.5 Eosinophilic Asthma Treatment Key Players Head office and Area Served
3.6 Key Players Eosinophilic Asthma Treatment Product Solution and Service
3.7 Date of Enter into Eosinophilic Asthma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Eosinophilic Asthma Treatment Breakdown Data by Type
4.1 Global Eosinophilic Asthma Treatment Historic Market Size by Type (2018-2023)
4.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Type (2024-2029)
5 Eosinophilic Asthma Treatment Breakdown Data by Application
5.1 Global Eosinophilic Asthma Treatment Historic Market Size by Application (2018-2023)
5.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Eosinophilic Asthma Treatment Market Size (2018-2029)
6.2 North America Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
6.4 North America Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Eosinophilic Asthma Treatment Market Size (2018-2029)
7.2 Europe Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
7.4 Europe Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Eosinophilic Asthma Treatment Market Size (2018-2029)
8.2 Asia-Pacific Eosinophilic Asthma Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Eosinophilic Asthma Treatment Market Size (2018-2029)
9.2 Latin America Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
9.4 Latin America Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Eosinophilic Asthma Treatment Market Size (2018-2029)
10.2 Middle East & Africa Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Eosinophilic Asthma Treatment Introduction
11.1.4 AstraZeneca Revenue in Eosinophilic Asthma Treatment Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Eosinophilic Asthma Treatment Introduction
11.2.4 GSK Revenue in Eosinophilic Asthma Treatment Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Genentech (Roche Group) & Novartis
11.3.1 Genentech (Roche Group) & Novartis Company Detail
11.3.2 Genentech (Roche Group) & Novartis Business Overview
11.3.3 Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Introduction
11.3.4 Genentech (Roche Group) & Novartis Revenue in Eosinophilic Asthma Treatment Business (2018-2023)
11.3.5 Genentech (Roche Group) & Novartis Recent Development
11.4 Regeneron Pharmaceuticals & Sanofi
11.4.1 Regeneron Pharmaceuticals & Sanofi Company Detail
11.4.2 Regeneron Pharmaceuticals & Sanofi Business Overview
11.4.3 Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Introduction
11.4.4 Regeneron Pharmaceuticals & Sanofi Revenue in Eosinophilic Asthma Treatment Business (2018-2023)
11.4.5 Regeneron Pharmaceuticals & Sanofi Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Eosinophilic Asthma Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Eosinophilic Asthma Treatment Business (2018-2023)
11.5.5 Teva Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Eosinophilic Asthma Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Intravenous Infusion
Table 3. Key Players of Subcutaneous Injection
Table 4. Global Eosinophilic Asthma Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Eosinophilic Asthma Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Eosinophilic Asthma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Eosinophilic Asthma Treatment Market Share by Region (2018-2023)
Table 8. Global Eosinophilic Asthma Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Eosinophilic Asthma Treatment Market Share by Region (2024-2029)
Table 10. Eosinophilic Asthma Treatment Market Trends
Table 11. Eosinophilic Asthma Treatment Market Drivers
Table 12. Eosinophilic Asthma Treatment Market Challenges
Table 13. Eosinophilic Asthma Treatment Market Restraints
Table 14. Global Eosinophilic Asthma Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Eosinophilic Asthma Treatment Market Share by Players (2018-2023)
Table 16. Global Top Eosinophilic Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Asthma Treatment as of 2022)
Table 17. Ranking of Global Top Eosinophilic Asthma Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Eosinophilic Asthma Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Eosinophilic Asthma Treatment Product Solution and Service
Table 21. Date of Enter into Eosinophilic Asthma Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Eosinophilic Asthma Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Eosinophilic Asthma Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Eosinophilic Asthma Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Eosinophilic Asthma Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Eosinophilic Asthma Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Eosinophilic Asthma Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Eosinophilic Asthma Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Eosinophilic Asthma Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Eosinophilic Asthma Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Eosinophilic Asthma Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Eosinophilic Asthma Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Eosinophilic Asthma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. AstraZeneca Company Detail
Table 47. AstraZeneca Business Overview
Table 48. AstraZeneca Eosinophilic Asthma Treatment Product
Table 49. AstraZeneca Revenue in Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 50. AstraZeneca Recent Development
Table 51. GSK Company Detail
Table 52. GSK Business Overview
Table 53. GSK Eosinophilic Asthma Treatment Product
Table 54. GSK Revenue in Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Genentech (Roche Group) & Novartis Company Detail
Table 57. Genentech (Roche Group) & Novartis Business Overview
Table 58. Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Product
Table 59. Genentech (Roche Group) & Novartis Revenue in Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 60. Genentech (Roche Group) & Novartis Recent Development
Table 61. Regeneron Pharmaceuticals & Sanofi Company Detail
Table 62. Regeneron Pharmaceuticals & Sanofi Business Overview
Table 63. Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Product
Table 64. Regeneron Pharmaceuticals & Sanofi Revenue in Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 65. Regeneron Pharmaceuticals & Sanofi Recent Development
Table 66. Teva Pharmaceuticals Company Detail
Table 67. Teva Pharmaceuticals Business Overview
Table 68. Teva Pharmaceuticals Eosinophilic Asthma Treatment Product
Table 69. Teva Pharmaceuticals Revenue in Eosinophilic Asthma Treatment Business (2018-2023) & (US$ Million)
Table 70. Teva Pharmaceuticals Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Eosinophilic Asthma Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Eosinophilic Asthma Treatment Market Share by Type: 2022 VS 2029
Figure 3. Intravenous Infusion Features
Figure 4. Subcutaneous Injection Features
Figure 5. Global Eosinophilic Asthma Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Eosinophilic Asthma Treatment Market Share by Application: 2022 VS 2029
Figure 7. Children Case Studies
Figure 8. Adults Case Studies
Figure 9. Teenagers Case Studies
Figure 10. Eosinophilic Asthma Treatment Report Years Considered
Figure 11. Global Eosinophilic Asthma Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Eosinophilic Asthma Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Eosinophilic Asthma Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Eosinophilic Asthma Treatment Market Share by Players in 2022
Figure 15. Global Top Eosinophilic Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Asthma Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Eosinophilic Asthma Treatment Revenue in 2022
Figure 17. North America Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 19. United States Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 23. Germany Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Eosinophilic Asthma Treatment Market Share by Region (2018-2029)
Figure 31. China Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Eosinophilic Asthma Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Eosinophilic Asthma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. AstraZeneca Revenue Growth Rate in Eosinophilic Asthma Treatment Business (2018-2023)
Figure 46. GSK Revenue Growth Rate in Eosinophilic Asthma Treatment Business (2018-2023)
Figure 47. Genentech (Roche Group) & Novartis Revenue Growth Rate in Eosinophilic Asthma Treatment Business (2018-2023)
Figure 48. Regeneron Pharmaceuticals & Sanofi Revenue Growth Rate in Eosinophilic Asthma Treatment Business (2018-2023)
Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Eosinophilic Asthma Treatment Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 外陰部痛管理のグローバル市場展望 2023年-2029年：経口、皮下注射
  • 好酸球性喘息治療薬のグローバル市場展望 2023年-2029年：点滴静注型、皮下注射型
  • 可換性バイオシミラーヒュミラ医薬品のグローバル市場展望 2023年-2029年：皮下注射、静脈注射
  • 閉経後骨粗鬆症治療薬のグローバル市場展望 2023年-2029年：経口式、皮下注射、静脈注射、その他
  • ウイルス性喘息治療の世界市場2023年：経口、注射
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8751 )"好酸球性喘息治療薬の世界市場2023年：静脈内注射、皮下注射" (英文：Global Eosinophilic Asthma Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。